Kadmon Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KADMON PHARMS LLC, and what generic alternatives to KADMON PHARMS LLC drugs are available?
KADMON PHARMS LLC has one approved drug.
There are five US patents protecting KADMON PHARMS LLC drugs.
There are forty-two patent family members on KADMON PHARMS LLC drugs in twenty-seven countries.
Summary for Kadmon Pharms Llc
International Patents: | 42 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Kadmon Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 11,311,541 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 10,183,931 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kadmon Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2006230159 | ⤷ Try a Trial |
Japan | 6703075 | ⤷ Try a Trial |
China | 113637008 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.